semaglutide patent expiry us 2031 Within weeks of the expiry, multiple Indian pharma companies launched their own versions. As a result, prices now range from ₹1290 to ₹4,500+ depending on the format. This is how semaglutide patent expiry us 2031

The evidence supporting this timing strategy comes from chronobiology principles rather than epitalon-specific trials

Semaglutide's effect on blood pressure is complex and varies significantly between individuals

16 Statistical significance was assessed by repeated measures ANOVA with post-hoc paired Students t -test

Medicare does not cover GLP-1 medications for weight loss under Part D, although the Medicare Bridge Program launched July 1, 2026 provides $50 per month for Wegovy pen, Wegovy pill, Zepbound KwikPen, and Foundayo for eligible Medicare beneficiaries with BMI 27 and above and an obesity-related comorbidity, running through December 31, 2027 (PeptideDeck)

Clinical, anthropometric and biochemical assessments were conducted at baseline, 12 weeks and 24 weeks